193 related articles for article (PubMed ID: 24039934)
1. Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis.
Saldana SM; Lee HH; Lowery FJ; Khotskaya YB; Xia W; Zhang C; Chang SS; Chou CK; Steeg PS; Yu D; Hung MC
PLoS One; 2013; 8(9):e73406. PubMed ID: 24039934
[TBL] [Abstract][Full Text] [Related]
2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
3. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
4. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
Carver KC; Piazza TM; Schuler LA
J Biol Chem; 2010 Mar; 285(11):8003-12. PubMed ID: 20080972
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
[TBL] [Abstract][Full Text] [Related]
6. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
7. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
10. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z
Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
[TBL] [Abstract][Full Text] [Related]
12. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
[TBL] [Abstract][Full Text] [Related]
13. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.
Lorenzatti G; Huang W; Pal A; Cabanillas AM; Kleer CG
J Cell Sci; 2011 May; 124(Pt 10):1752-8. PubMed ID: 21525039
[TBL] [Abstract][Full Text] [Related]
14. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
15. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
16. ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.
Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer; 2010 Sep; 9():235. PubMed ID: 20825649
[TBL] [Abstract][Full Text] [Related]
17. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
18. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
19. Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.
Hiraga T; Myoui A; Hashimoto N; Sasaki A; Hata K; Morita Y; Yoshikawa H; Rosen CJ; Mundy GR; Yoneda T
Cancer Res; 2012 Aug; 72(16):4238-49. PubMed ID: 22738911
[TBL] [Abstract][Full Text] [Related]
20. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
